爱妃传媒

Could This Toothpaste Prevent a Heart Attack or Stroke?

PlaqueHD, Toothpaste, Heart Attack, Stroke, Inflammation, Atherosclerosis, Study, Randomized Trial, Gum Disease, Periodontal Disease, Medicine

Photo Credit: Plaque HD庐


By gisele galoustian | 2/24/2020

For decades, researchers have suggested a link between oral health and inflammatory diseases affecting the entire body 鈥 in particular, heart attacks and strokes. Inflammation is intimately involved in the pathogenesis of atherosclerosis and is accurately measured by high sensitivity C-reactive protein (hs-CRP), a sensitive marker for future risks of heart attacks and strokes. 聽

Researchers from 爱妃传媒鈥檚 , , and the , collaborated on a randomized trial titled, 鈥淐orrelation between Oral Health and Systemic Inflammation鈥 (COHESION), to further explore whether 庐, a plaque identifying toothpaste, reduces hs-CRP.聽聽

Results of the randomized pilot trial, published online ahead of print in the , showed that Plaque HD庐 produced a statistically significant reduction in hs-CRP among those with elevations at baseline. Plaque HD庐 is the first toothpaste that identifies plaque so that it can be removed with directed brushing. In addition, the product鈥檚 proprietary formulation contains unique combinations and concentrations of cleaning agents that weaken the core of the plaque structure to help the subject visualize and more effectively remove the plaque.聽

In this trial, all randomized subjects were given the same brushing protocol and received a 30-day supply of toothpaste containing either Plaque HD庐 or an identical non-plaque identifying placebo toothpaste. To assess hs-CRP, levels were measured by Quest Diagnostics using an enzyme linked immunosorbent assay.聽

鈥淭he current findings are similar to those from our previous pilot trial,鈥 said , M.D., Dr.P.H., senior author, first Sir Richard Doll Professor, and senior academic advisor in 爱妃传媒鈥檚 Schmidt College of Medicine. 鈥淲hether this plaque-identifying toothpaste decreases heart attacks or strokes requires a large-scale randomized trial of sufficient size and duration. These results provide a stronger rationale to conduct such trials. If positive, the results of these trials would have significant potential clinical and public health implications.鈥

Based on these findings, Hennekens and colleagues at 爱妃传媒 and the University of Wisconsin School of Medicine and Public Health are drafting an investigator-initiated research grant proposal to the National Institutes of Health (NIH). Their proposed randomized trial will test whether Plaque HD庐 reduces progression of atherosclerosis in the coronary and carotid arteries, for which systemic inflammation is an important precursor.

A report from the United States Centers for Disease Control and Prevention found that 47.2 percent of American adults aged 30 years and older have some form of , a pathological inflammatory condition of the gums and tissues surrounding the teeth. Periodontal disease increases with age affecting more than 70 percent聽of adults 65 years and older. Prior research has suggested that periodontal disease may be connected to a variety of other diseases, including heart disease and stroke and other inflammatory diseases such as rheumatoid arthritis. Inflammation throughout the body may be a crucial link between periodontal and other systemic diseases.聽

Further, two years ago, the prestigious New England Journal of Medicine ranked the original manuscript published in 1997 by Hennekens and colleagues on aspirin, inflammation and cardiovascular disease, as their most influential original report of the last 20 years. Those randomized data derived from the landmark Physician鈥檚 Health Study, in which Hennekens was the founding principal investigator, and suggested that hs-CRP predicted future heart attacks and strokes.

Co-authors of this randomized pilot trial are Amit Acharya, Ph.D., Marshfield Clinic Research Center and the University of Wisconsin School of Medicine and Public Health; Ingrid Glurich, Ph.D, Marshfield Clinic Research Center; and Scott Hetzel, M.S., KyungMann Kim, Ph.D., Matthew C. Tattersall, D.O., F.A.C.C.; and David L. DeMets, Ph.D., all with the University of Wisconsin School of Medicine and Public Health.

-爱妃传媒-